Medtronic Unveils Inceptiv, World’s First Rechargeable Closed-Loop Spinal Cord Stimulator, in Asia-Pacific Debut at CIIE

(Source: Labor Newspaper)

Source: Labor Daily

Chronic pain, such as painful diabetic peripheral neuropathy and postherpetic neuralgia, is a serious condition that significantly reduces the quality of life. Spinal cord stimulation is one of the core treatment technologies for chronic pain recognized internationally. At this year's CIIE, Medtronic, the pioneer of spinal cord stimulation, unveiled the Asia-Pacific premiere of Inceptiv, the world’s first rechargeable closed-loop spinal cord neurostimulator.

Spinal Cord Stimulator Improves Pain and Quality of Life for Patients with Chronic Intractable Pain and Painful Diabetic Peripheral Neuropathy

Compared with traditional spinal cord stimulators, Inceptiv can "listen to the body's signals," sense changes in spinal cord bio-signals during different movements, and automatically adjust stimulation in real time to ensure patients receive more consistent and stable treatment outcomes. It also features the globally leading Overdrive patented battery technology with an open lifespan, providing patients with longer-term safe and reliable therapy. Additionally, it does not interfere with patients undergoing MRI scans, achieving full-body compatibility with both 1.5T and 3.0T MRI systems without being affected by impedance or posture restrictions.

Ms. Chen Jianrong, Senior Director of Medtronic's Neuromodulation Business in Greater China, stated: "The CIIE is a key platform for Medtronic to introduce global innovative technologies into China's healthcare system. The Asia-Pacific premiere of Incepti has broken the geographical barriers of high-end pain treatment technology. We hope to leverage the 'spillover effect' of the CIIE to accelerate the clinical implementation and popularization of this innovative therapy in China, driving the continuous improvement of overall pain diagnosis and treatment standards."